drugset / Trial / NCT01393119

Phase II, Dose Finding Study of GTx-758

NCT01393119

Phase 2 Terminated 77 enrolled GTx
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to determine the appropriate loading and maintenance dose of GTx-758 to reach and maintain castration for the duration of the study.

Timeline

Start
2011-08
Primary completion
2012-12
Completion
2012-12

Drugs

EvaluationDrugModalityDoseRoute
Subject GTx-758 Small molecule 1000 mg
Subject GTx-758 Small molecule 2000 mg

Indications